[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU48102B - Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen - Google Patents

Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen

Info

Publication number
YU48102B
YU48102B YU184790A YU184790A YU48102B YU 48102 B YU48102 B YU 48102B YU 184790 A YU184790 A YU 184790A YU 184790 A YU184790 A YU 184790A YU 48102 B YU48102 B YU 48102B
Authority
YU
Yugoslavia
Prior art keywords
adhesive
flaster
procedure
making
active material
Prior art date
Application number
YU184790A
Other languages
English (en)
Other versions
YU184790A (sh
Inventor
H.R. Hoffmann
R.P. Klein
R. Meconi
G. Cordes
H.M. Wolff
Original Assignee
Lts. Lohmann Therapie-Systeme Gmbh. & Co. Kg.
Schwarz Pharma Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU48102(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts. Lohmann Therapie-Systeme Gmbh. & Co. Kg., Schwarz Pharma Ag. filed Critical Lts. Lohmann Therapie-Systeme Gmbh. & Co. Kg.
Priority to SI9011847A priority Critical patent/SI9011847B/sl
Publication of YU184790A publication Critical patent/YU184790A/sh
Priority to HR930676A priority patent/HRP930676B1/xx
Publication of YU48102B publication Critical patent/YU48102B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/12—Stiffening bandages containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Adhesive Tapes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

POSTUPAK ZA IZRADU FLASTERA SA AKTIVNOM MATERIJOM KOJI SADRŽI ESTROGEN za kontrolisano odavanje aktivnih materija na kožu, koji se sastoji od zadnjeg sloja i u vodi nerastvornog lepljivog filma od lepka za prianjanje sa tim spojen, koji sadrži polimere koji mogu da bubre u vodi i u kome je aktivna materija bar delimično rastvorna, i iz zaštitnog sloja koji može ponovo da se odvoji koji pokriva lepljivi film, naznačen time, što se lepljiva masa na bazi homo-i/ili kopolimera homogenizuje sa bar jednim derivatom akrilne ili metakrilne kiseline, pri čemu se kao predhodno ili jednovremeno dodata aktivna materija upotrebljavaju estrogeni i njihovi farmaceutski prihvatljivi derivati sami ili u kombinaciji sa gestagenima, što se masa nanosi na ponovo odvojivi zaštitni sloj ili odvojiv međusloj i posle otparavanja rastvarača pokriva za aktivnu materiju nepropusnim zadnjim slojem. Prijava sadrži još 10 zavisnih zahteva.
YU184790A 1989-10-06 1990-10-01 Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen YU48102B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9011847A SI9011847B (sl) 1989-10-06 1990-10-01 Postopek za izdelavo obliža z dejavno snovjo, vsebujočega estrogen
HR930676A HRP930676B1 (en) 1989-10-06 1993-04-01 Process for the production of an active substance plaster containing estrogen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3933460A DE3933460A1 (de) 1989-10-06 1989-10-06 Oestrogenhaltiges wirkstoffpflaster

Publications (2)

Publication Number Publication Date
YU184790A YU184790A (sh) 1992-12-21
YU48102B true YU48102B (sh) 1997-03-07

Family

ID=6390993

Family Applications (1)

Application Number Title Priority Date Filing Date
YU184790A YU48102B (sh) 1989-10-06 1990-10-01 Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen

Country Status (26)

Country Link
US (1) US5393529A (sh)
EP (1) EP0421454B2 (sh)
JP (1) JP2766864B2 (sh)
KR (1) KR960004300B1 (sh)
AT (1) ATE126069T1 (sh)
AU (1) AU637637B2 (sh)
CA (1) CA2027053C (sh)
CZ (1) CZ282363B6 (sh)
DE (2) DE3933460A1 (sh)
DK (1) DK0421454T3 (sh)
ES (1) ES2078929T5 (sh)
FI (1) FI100380B (sh)
GR (2) GR3017851T3 (sh)
HR (1) HRP930676B1 (sh)
HU (1) HU206831B (sh)
IE (1) IE72141B1 (sh)
IL (1) IL95776A (sh)
MY (1) MY106628A (sh)
NO (1) NO303321B1 (sh)
NZ (1) NZ235581A (sh)
PL (1) PL165270B1 (sh)
PT (1) PT95505B (sh)
SI (1) SI9011847B (sh)
SK (1) SK279514B6 (sh)
YU (1) YU48102B (sh)
ZA (1) ZA907969B (sh)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
US5827245A (en) * 1992-07-16 1998-10-27 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
DE4223360C1 (sh) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4230588C1 (de) * 1992-09-12 1993-10-07 Lohmann Therapie Syst Lts Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung
DE4237453C1 (sh) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4319096C1 (de) * 1993-06-08 1994-09-08 Kuhl Herbert Prof Dr Phil Nat Hormonales Mittel zur Vorbeugung und Behandlung arterieller Erkrankungen beim Mann
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
DE4403487C2 (de) * 1994-02-04 2003-10-16 Lohmann Therapie Syst Lts Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
DE69625483T3 (de) * 1995-06-07 2012-05-10 Ortho-Mcneil Pharmaceutical, Inc. Transdermales pflaster zur verabreichung von 17-deacetyl norgestimat in kombination mit einem östrogen
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
US6623763B2 (en) 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
AU732803B2 (en) * 1996-01-17 2001-05-03 National Starch And Chemical Investment Holding Corporation Adhesives resistant to skin-penetration enhancers
DE19700913C2 (de) 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
KR20010052600A (ko) * 1998-06-05 2001-06-25 한스 크리스토프 빌크, 미하엘 베르크만 자립형 접착성 성형품
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US7223418B2 (en) * 2000-03-07 2007-05-29 Tiejin Limited Stretchable patch
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20040039356A1 (en) * 2000-10-16 2004-02-26 Masayoshi Maki Compositions for external preparations
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
KR100448469B1 (ko) * 2001-10-26 2004-09-13 신풍제약주식회사 항염증제의 경피 조성물 및 장치
DE10157745A1 (de) * 2001-11-24 2003-06-26 Hf Arzneimittelforsch Gmbh Transdermales therapeutisches System zur Verabreichung von 17alpha-Estradiol
JP4295467B2 (ja) * 2002-04-12 2009-07-15 日東電工株式会社 貼付剤およびその製造方法
JP4323138B2 (ja) * 2002-06-05 2009-09-02 日東電工株式会社 経皮吸収型製剤およびその製造方法
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
JP4919573B2 (ja) * 2002-08-09 2012-04-18 帝國製薬株式会社 ノルエチステロン含有外用貼付剤
JP5027373B2 (ja) * 2002-08-09 2012-09-19 帝國製薬株式会社 エストラジオール含有貼付剤
AU2003254834B2 (en) * 2002-08-09 2009-02-19 Fuso Pharmaceutical Industries, Ltd. Female hormone-containing patch
EP1426049B1 (en) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US20040208917A1 (en) * 2003-04-16 2004-10-21 Wilfried Fischer Transdermal systems for the release of clonidine
ITMI20041492A1 (it) * 2004-07-23 2004-10-23 Italiano Biochimico Far Maceut Nuovo dispositivo per il rilascio di principi attivi
KR100663163B1 (ko) 2005-10-24 2007-01-02 (주)아모레퍼시픽 비스테로이드성 소염진통제를 함유하는 경피 투여 제제
CA2678873C (en) 2007-02-19 2016-10-25 Plurogen Therapeutics, Inc. Compositions for treating biofilms and methods for using same
WO2008154368A2 (en) 2007-06-08 2008-12-18 University Of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
US20100292660A1 (en) * 2007-07-10 2010-11-18 Agis Kydonieus Dermal delivery device with ultrasonic weld
CA2692884C (en) 2007-07-10 2016-09-20 Agile Therapeutics, Inc. Dermal delivery device with in situ seal
US20100178323A1 (en) 2007-07-10 2010-07-15 Agis Kydonieus Dermal Delivery Device
ES2734510T3 (es) 2008-10-08 2019-12-10 Agile Therapeutics Inc Administración transdérmica
EP2343979B1 (en) 2008-10-08 2020-04-08 Agile Therapeutics, Inc. Transdermal delivery
EP2343964A4 (en) 2008-10-08 2012-11-07 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
EP2410859A4 (en) 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
EP2437755B1 (en) 2009-05-19 2017-04-12 Plurogen Therapeutics, LLC Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing
JP5652867B2 (ja) * 2009-11-20 2015-01-14 日東電工株式会社 医療用粘着剤組成物
EP2377540A1 (en) 2010-03-31 2011-10-19 Hexal AG Transdermal patch containing 17-deacetyl norgestimate
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
KR102240525B1 (ko) 2013-12-31 2021-04-16 존슨 앤드 존슨 컨수머 인코포레이티드 다층의 형상화된 필름을 형성하기 위한 방법
ES2703210T3 (es) 2013-12-31 2019-03-07 Johnson & Johnson Consumer Inc Proceso en un solo paso para la formación de un producto en la forma de película de capas múltiples, producto y aparato
ES2977380T3 (es) 2013-12-31 2024-08-22 Johnson & Johnson Consumer Inc Proceso para formar un producto de película conformado
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
AU2015316523A1 (en) 2014-09-18 2017-05-04 Neuroderm, Ltd. Opipramol patch
EP3247364A4 (en) 2015-01-20 2018-10-24 Plurogen Therapeutics, LLC Compositions and methods of treating microbes
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
DE102018120505A1 (de) 2017-10-20 2019-04-25 Amw Gmbh Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6902314A (sh) * 1969-02-13 1970-08-17
US3993815A (en) * 1974-10-07 1976-11-23 Avery Products Corporation Anaerobic pressure sensitive adhesive stocks
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPS5620515A (en) * 1979-07-30 1981-02-26 Suzuki Nihondou:Kk Preparation of plaster
CA1163195A (en) * 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
IN155486B (sh) * 1981-03-16 1985-02-09 Johnson & Johnson Prod Inc
AU553343B2 (en) * 1981-08-10 1986-07-10 Advance Electrode Kabushikikaisya Absorbent adhesive bandage with medicament release
JPS59175419A (ja) * 1983-03-25 1984-10-04 Nitto Electric Ind Co Ltd 外用部材
JPS60123417A (ja) * 1983-12-07 1985-07-02 Nitto Electric Ind Co Ltd 薬物投与部材
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
DE3587616D1 (de) * 1984-12-22 1993-11-11 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
JPS61155320A (ja) * 1984-12-28 1986-07-15 Taisho Pharmaceut Co Ltd 貼付剤
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4906169A (en) * 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (sh) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US4789547A (en) * 1987-06-17 1988-12-06 Warner-Lambert Company Transdermal matrix system
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system

Also Published As

Publication number Publication date
IL95776A (en) 1994-10-07
HRP930676A2 (en) 1994-10-31
GR3017851T3 (en) 1996-01-31
HU206831B (en) 1993-01-28
GR3033662T3 (en) 2000-10-31
HU906356D0 (en) 1991-04-29
IL95776A0 (en) 1991-06-30
KR960004300B1 (en) 1996-03-30
EP0421454A2 (de) 1991-04-10
FI100380B (fi) 1997-11-28
US5393529A (en) 1995-02-28
HUT56290A (en) 1991-08-28
NO303321B1 (no) 1998-06-29
SI9011847B (sl) 1999-08-31
IE903572A1 (en) 1991-04-10
CS9004859A2 (en) 1991-10-15
SI9011847A (sl) 1998-06-30
NZ235581A (en) 1993-03-26
DE59009495D1 (de) 1995-09-14
EP0421454B1 (de) 1995-08-09
ES2078929T3 (es) 1996-01-01
CZ282363B6 (cs) 1997-07-16
DE3933460A1 (de) 1991-04-18
PT95505A (pt) 1991-08-14
ATE126069T1 (de) 1995-08-15
KR910007548A (ko) 1991-05-30
YU184790A (sh) 1992-12-21
ZA907969B (en) 1991-08-28
CA2027053C (en) 1998-04-28
EP0421454B2 (de) 2000-04-05
JP2766864B2 (ja) 1998-06-18
AU6312890A (en) 1991-04-11
SK279514B6 (sk) 1998-12-02
CA2027053A1 (en) 1991-04-07
EP0421454A3 (en) 1991-06-12
NO904338L (no) 1991-04-08
JPH03204811A (ja) 1991-09-06
HRP930676B1 (en) 2000-10-31
AU637637B2 (en) 1993-06-03
ES2078929T5 (es) 2000-08-16
NO904338D0 (no) 1990-10-05
MY106628A (en) 1995-06-30
PL165270B1 (pl) 1994-12-30
IE72141B1 (en) 1997-03-26
DK0421454T3 (da) 1995-08-09
DE3933460C2 (sh) 1992-03-26
PL287200A1 (en) 1991-08-12
PT95505B (pt) 2001-04-30
FI904888A0 (fi) 1990-10-04

Similar Documents

Publication Publication Date Title
YU48102B (sh) Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen
AU614209B2 (en) Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof
YU226090A (sh) Postupak za izradu transdermalnog terapijskog sistema sa buprenorphinom kao aktivnim sastojkom
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
IT1243745B (it) Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
BE905568R (fr) Procede et dispositif d'administration transdermique de medicament.
NO895172D0 (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
ES2053528T5 (es) Composicion farmaceutica que comprende un medicamento y un polimero hinchable en agua.
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu